PHIO
PHIO
NASDAQ · Biotechnology

Phio Pharmaceuticals Corp

$0.92
+0.06 (+7.39%)
As of Feb 8, 2:29 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,444.2% upside
Low Target $25.28
Average Target $32.61
High Target $46.79
Current Price $0.92
Current
$0.92
Target
$32.61
$25.28 $32.61 avg $46.79
Scenario Analysis
Bear Case
$25.28
2,647.5%
Low target
Base Case
$32.61
+3,444.2%
Avg target
Bull Case
$46.79
+4,985.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$29.62
-96.9% from high
52-Week Low
$16.04
+-94.3% from low
Target vs 52W High
$32.61
+10.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%